Real-time enrollment status for this diabetic retinopathy clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 2:25 PM UTC
| NCT Number | NCT06321302 |
| Recruiting Status | Recruiting |
| Condition | Diabetic Retinopathy |
| Phase | PHASE2 |
| Target Enrollment | 175 participants |
| Active Locations | 40 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | October 15, 2026 (14 hours ago) |
As of October 15, 2026: Clinical trial NCT06321302 is currently recruiting participants. This phase2 study for diabetic retinopathy is actively seeking new participants at 40 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06321302 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 40 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06321302 was last updated 14 hours ago (October 15, 2026). HelloStudys verifies this status automatically.